';

O3 Enterprise Closes Record-Breaking Year: Turnover Reaches €6 Million (+50%) and Profitability Doubles

The company strengthens its position in the digital healthcare market by focusing on high-value-added projects. Stefano Fait is appointed as the new CEO.
New Features – June 2025

O3 Enterprise, a Trieste-based company specializing in technological innovation applied to digital healthcare, proudly announces financial results that mark a historic milestone in its development journey.

The fiscal year concluded with a turnover of €6 million, marking a 50% increase over the previous year’s €4 million, and a doubling of EBITDA (+100%).

These figures mark the beginning of a strategic phase aimed at consolidating our leadership in innovation. Today, the company has over 30 professionals and a strengthened territorial presence: the new Milan office now joins the historic headquarters in Trieste and Gorizia.

Drivers of Growth

A Key Partner for Healthcare and Public Administration

Today’s results validate the success of the 2022-2025 Industrial Plan, a roadmap shared by the founding partners and led by Lorenzo Rizzatto in his role as CEO.

Growth was primarily driven by the ability to integrate O3’s ZEEROmed solutions into complex digital transition projects across regional and national application scenarios, becoming a strategic partner for the most significant market players in Italy.

Today, the company stands as an innovative interlocutor for Public Administration and major private healthcare groups.

sanità digitale
Stefano Fait CEO
Leadership change

2026-2030 industrial plan

With the approval of the financial statements, O3 Enterprise officially inaugurates its new Industrial Plan with a 2030 horizon.

To support these ambitions, the corporate governance is evolving: Stefano Fait assumes the role of Chief Executive Officer, succeeding Lorenzo Rizzatto.

The Board of Directors confirms Andrea Poli as Board President, while Rizzatto will continue his commitment on the Board as Vice President.

This year's results are not just numbers; they are proof of the solidity of our vision - stated the leadership - The shift to a €6 million turnover and the doubling of EBITDA confirm the validity of the path taken in 2022. Today, we are ready to write a new chapter: our technology is generating real value for the healthcare system and for citizens on a national scale, laying a rock-solid foundation for the 2026-2030 plan.
Future Outlook

Internationalization and R&D

Financial stability and an international vision will guide O3 Enterprise toward 2030. The goal for the next five years is to consolidate its national market share and accelerate expansion into foreign markets.

At the heart of the strategy remains a decisive commitment to invest in Research and Development, an essential lever to continue leading the evolution of Italian and international digital healthcare.

logo